Unicycive Therapeutics Q4 EPS $(0.35) Misses $(0.17) Estimate

UNICYCIVE THERAPEUTICS, INC. +0.51% Post

UNICYCIVE THERAPEUTICS, INC.

UNCY

0.84

0.84

+0.51%

0.00% Post

Unicycive Therapeutics (NASDAQ: UNCY) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.17) by 105.88 percent. This is a 31.37 percent increase over losses of $(0.51) per share from the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via